Skip to Main Content (Press Enter)
×
Home
Corsi
Insegnamenti
Persone
Pubblicazioni
Competenze
IT
EN
☰
UNI-FIND
|
UNI-FIND
hunimed.eu
IT
EN
×
Home
Corsi
Insegnamenti
Persone
Pubblicazioni
Competenze
☰
Pubblicazioni
BLOOD ADVANCES
Rivista
Codice:
E247527
ISSN:
2473-9529
Dati Generali
Dati Generali
Pubblicazioni (33)
Pulisci
Ordina Pubblicazioni:
crescente
decrescente
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis
Articolo
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
Articolo
American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing
Articolo
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients
Articolo
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis
Articolo
American Society of Hematology, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panamena de Hematología, Sociedad Peruana de Hematología, and SVH 2023 guidelines for diagnosis of venous thromboembolism and for its management in special populations in Latin America
Articolo
American Society of Hematology, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, Sociedad Peruana de Hematología, and SVH 2022 guidelines for prevention of venous thromboembolism in surgical and medical patients and long-distance travelers in Latin America
Recensione
Analysis of factor V in zebrafish demonstrates minimal levels needed for early hemostasis
Articolo
Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trial
Articolo
Brentuximab Vedotin and Chemotherapy in Relapsed/Refractory Hodgkin Lymphoma: a Propensity Score Matched Analysis
Articolo
CD19 antibody-drug conjugate therapy in DLBCL does not preclude subsequent responses to CD19-directed CAR T-cell therapy
Articolo
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML
Articolo
Checkpoint inhibition before haploidentical transplantation with posttransplant cyclophosphamide in Hodgkin Lymphoma
Articolo
Clinical outcomes of older and younger patients treated with loncastuximab tesirine in the LOTIS-2 clinical trial
Articolo
Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database
Articolo
DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines
Articolo
Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma
Articolo
How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines
Articolo
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy
Articolo
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial
Articolo
Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma: a subgroup analysis from the LOTIS-2 study
Articolo
MGUS and clonal hematopoiesis show unrelated clinical and biological trajectories in an older population cohort
Articolo
Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses
Articolo
Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up
Articolo
Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from pivotal phase 2 CheckMate 205 study
Articolo
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma
Articolo
Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines
Articolo
Prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures during FVIII inhibitor eradication
Articolo
Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma
Articolo
Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment
Articolo
Second primary malignancies in ruxolitinib-treated myelofibrosis: Real-world evidence from 219 consecutive patients
Articolo
Selected memory T cells infused post haploidentical hematopoietic stem cell transplantation persist and hyper-expand
Abstract
Therapy-related myelofibrosis does not appear to exist
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
